share_log

12 Health Care Stocks Moving In Tuesday's Intraday Session

Benzinga ·  May 8 00:31

Gainers

  • Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today.
  • Bioventus (NASDAQ:BVS) stock moved upwards by 28.87% to $5.16. The market value of their outstanding shares is at $329.0 million. The company's, Q1 earnings came out today.
  • Design Therapeutics (NASDAQ:DSGN) stock rose 28.49% to $4.69. The market value of their outstanding shares is at $264.9 million.
  • Acutus Medical (NASDAQ:AFIB) stock moved upwards by 24.11% to $0.13. The company's market cap stands at $3.9 million.
  • Oragenics (AMEX:OGEN) shares moved upwards by 22.78% to $1.33. The market value of their outstanding shares is at $5.9 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) shares moved upwards by 22.61% to $1.2.

Losers

  • Neuronetics (NASDAQ:STIM) stock declined by 33.1% to $2.51 during Tuesday's regular session. The company's market cap stands at $75.2 million. As per the news, the Q1 earnings report came out today.
  • Helius Medical Tech (NASDAQ:HSDT) shares decreased by 25.62% to $1.8. The market value of their outstanding shares is at $1.5 million.
  • Allarity Therapeutics (NASDAQ:ALLR) stock declined by 20.08% to $0.72. The market value of their outstanding shares is at $1.7 million.
  • Lyra Therapeutics (NASDAQ:LYRA) stock fell 17.86% to $0.43. The market value of their outstanding shares is at $26.1 million.
  • GlucoTrack (NASDAQ:GCTK) stock decreased by 16.28% to $0.64. The market value of their outstanding shares is at $17.1 million.
  • Talkspace (NASDAQ:TALK) stock declined by 15.1% to $2.7. The company's market cap stands at $458.0 million. The company's, Q1 earnings came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment